Scientifica Venture Capital and Recordati join forces to promote open innovation between start-ups and leading companies in the Medtech & Life Science sector

Scientifica Venture Capital and Recordati have entered into a strategic partnership to foster open innovation between start-ups and leading companies in the Medtech & Life Science sector. Scientifica Venture Capital, specializing in financing scientific and technological start-ups, will provide financial support and expertise in identifying promising start-ups for investment and accelerating the innovation process. Recordati, a global leader in the pharmaceutical industry, will contribute its knowledge, resources, and distribution networks to support the growth and expansion of selected entrepreneurial ventures that require industrial validation of their pharmaceutical products and market testing in the distribution field.

The partnership is built on the principle of open innovation and represents a significant step in creating an ecosystem that promotes collaboration between the start-up world and large companies in the Medtech & Life Science field. Both parties share a common goal of supporting the development of innovative scientific solutions that enhance people’s lives, while jointly addressing the complex global challenges in the sector.

Riccardo D’Alessandri, Managing Partner of Scientifica Venture Capital, expresses enthusiasm about the collaboration, stating, “We are excited to collaborate with Recordati to advance open innovation in the pharmaceutical and medical technology and biomedicine sectors. This unique partnership will create synergies of ideas, knowledge, experiences, and resources between the start-up world and a leading pharmaceutical group, leading to new discoveries and innovations that can significantly enhance people’s quality of life worldwide.

“Massimo Grandi, VP Southern Europe Region and General Manager Pharmaceuticals Italy, Specialty & Primary Care at Recordati, highlights the company’s commitment to improving health and quality of life. He states, “Recordati has always been committed to improving people’s health and quality of life. We are delighted to promote open innovation with Scientifica Venture Capital, supporting the most promising start-ups in the scientific field and accelerating the development process of cutting-edge technological solutions.”

The partnership between Scientifica Venture Capital and Recordati signifies an exciting collaboration that aims to drive innovation and positively impact the Medtech & Life Science sector. For further information about Scientifica Venture Capital, you can access the company profile and media kit through the provided link.